Biomarker

Open Access
Proximity Mapping of the ER Proteome Reveals Metastasis-specific Candidate Biomarkers in Breast Cancer Cell Lines
MEHMET SARIHAN, ELIFCAN KOCYIGIT, MURAT KASAP and GURLER AKPINAR

Cancer Genomics & Proteomics May 2026, 23 (3) 483-502; DOI: https://doi.org/10.21873/cgp.20586
Open Access
Exosomes Transfer ST6GAL1-mediated Therapeutic Resistance in Rectal Cancer Cells
JEREMIE M. P. LEVER, REGINA K. IRWIN, VIVEK SOMASUNDARAM, YUWEI SONG, CHANDLER M. MCLEOD, MARY SMITHSON, GREGORY WILLIAMS, ZECHEN CHONG and KARIN M. HARDIMAN

Cancer Genomics & Proteomics January 2026, 23 (1) 12-26; DOI: https://doi.org/10.21873/cgp.20558
Open Access
Comparative Transcriptomic Analysis Identifies Predictive Biomarkers of Pathological Complete Response in Triple-negative Breast Cancer
FANG-MING CHEN, CHUNG-LIANG LI, MEI-REN PAN, YUN-CIAN HUANG, LI-JU HUANG, SIN-HUA MOI, SHU-JYUAN CHANG, PING-FU YANG, CHIEH-NI KAO, JUNG-YU KAN, LI-KUN KO, HIDENOBU TAKAHASHI, CHIA-YU KUO, SHEN-LIANG SHIH, MING-FENG HOU, YI-HSIUNG LIN and CHI-WEN LUO

Cancer Genomics & Proteomics January 2026, 23 (1) 66-80; DOI: https://doi.org/10.21873/cgp.20561
Open Access
Circulating Serum piRNAs as Diagnostic and Prognostic Tools for Clear Cell Renal Cell Carcinoma
MAREK KASIK, ROBERT ILIEV, PETRA VYCHYTILOVA, SILVIA RYBECKA, LENKA RADOVA, MICHAL STANIK, MICHAL FEDORKO, JAN DOLEZEL, ONDREJ SLABY and JULIA BOHOSOVA

Cancer Genomics & Proteomics November 2025, 22 (6) 888-899; DOI: https://doi.org/10.21873/cgp.20545
Open Access
FAM32A Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer
YUYA AGATSUMA, DAI SHIMIZU, SHINICHI UMEDA, HARUYOSHI TANAKA, NORIFUMI HATTORI, MASAMICHI HAYASHI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA, MICHITAKA FUJIWARA and YASUHIRO KODERA

Cancer Genomics & Proteomics January 2025, 22 (1) 55-69; DOI: https://doi.org/10.21873/cgp.20487
Open Access
Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma
SUPAKAN AMONTAILAK, ATTAPOL TITAPUN, APINYA JUSAKUL, RAYNOO THANAN, PHONGSARAN KIMAWAHA, WASSANA JAMNONGKAN, MALINEE THANEE, PAPITCHAYA SIRITHAWAT, SONGPOL HAOHAN and ANCHALEE TECHASEN

Cancer Genomics & Proteomics January 2025, 22 (1) 81-89; DOI: https://doi.org/10.21873/cgp.20489
Open Access
Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
SACHIKO INUBUSHI, TOMONARI KUNIHISA, MARINA KUNIYASU, SHOTARO INOUE, MAYUKO YAMAMOTO, YUJI YAMASHITA, MAYUKO MIKI, SACHIKO MIZUMOTO, MOTOI BABA, ROBERT M. HOFFMAN and HIROKAZU TANINO

Cancer Genomics & Proteomics November 2024, 21 (6) 580-584; DOI: https://doi.org/10.21873/cgp.20474
Open Access
Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer
KEIKO SATO, KENTARO MIURA, SHOMA TAMORI and KAZUNORI AKIMOTO

Cancer Genomics & Proteomics May 2024, 21 (3) 316-326; DOI: https://doi.org/10.21873/cgp.20450
Open Access
Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer
GABRIEL HENRIQUE CAXALI, LAÍZA BRUGNEROTTO, MIRIAN CAROLINI ESGOTI AAL, CAMILA FERREIRA BANNWART CASTRO and FLÁVIA KARINA DELELLA

Cancer Genomics & Proteomics September 2023, 20 (5) 487-499; DOI: https://doi.org/10.21873/cgp.20400
Open Access
OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus
DAI SHIMIZU, MITSURO KANDA, TAKAYOSHI KISHIDA, SHUNSUKE NAKAMURA, MASAHIRO SASAHARA, SEI UEDA, YUSUKE SATO, YOSHIKUNI INOKAWA, NORIFUMI HATTORI, MASAMICHI HAYASHI, CHIE TANAKA, SATORU MOTOYAMA and YASUHIRO KODERA

Cancer Genomics & Proteomics July 2023, 20 (4) 343-353; DOI: https://doi.org/10.21873/cgp.20386

Main menu

User menu

Search

Biomarker

Pages